Wanna Talk to the FDA? (CureCast Episode 146)

Today, we are discussing Patient Focused Drug Development (PFDD) for SCI with Ian Burkhart. The PFDD is an authoritative process initiated and recognized by the Food and Drug Administration for identifying the treatment priorities of the people who live with certain diseases or conditions. Ian is an influential, lived-experience advocate in the SCI community. He is the past President of the North American Spinal Cord Injury Association (NASCIC) and is one of the principal organizers of the PFDD. This process is incredibly important and has been referred to as a “once in a generation” opportunity. What should you know up front before we unpack all the details of the PFDD? Its main feature is a virtual community meeting where the SCI community can address the FDA about what is important to us! Which is why we need you to be present. Whether you live with an SCI, are a caregiver, researcher, clinician, funder, whatever. We are shooting for 1000 people to be present and hope to surpass that number. The meeting is September 29th and you can register to attend at www.scipfdd.org. More info: https://u2fp.org/get-educated/curecast/episode-146.html